Alfred L. Garfall
0000-0003-2791-5748
Publication & Citation Trends
Most Cited Works
Publications
310 total
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer.
Cited by 0
Semantic Scholar
CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy
Cited by 0
Semantic Scholar
Long-Term Quality of Life, Cognitive Function, and Symptom Burden Among Chimeric Antigen Receptor T-Cell Recipients and Associated Cytokine Release Syndrome and Neurotoxicity.
Cited by 2
Semantic Scholar
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies
Cited by 56
Semantic Scholar
Factors Related to Long-Term Caregiving Burden Among Chimeric Antigen Receptor (CAR) T-Cell Recipients and Their Informal Caregivers.
Cited by 0
Semantic Scholar
Long-term Financial Toxicity after CAR T-cell Therapy among Patients in Remission and Their Caregivers.
Cited by 1
Semantic Scholar
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy
Cited by 241
OpenAlex
Implementation of an Approach to Equitable Allocation of SARS-CoV-2 Monoclonal Antibodies for Preexposure Prophylaxis: Experience From a Single Medical Center OA
Cited by 1
Semantic Scholar
Research Topics
Multiple Myeloma Research and Treatments
(195)
CAR-T cell therapy research
(141)
Monoclonal and Polyclonal Antibodies Research
(45)
Protein Degradation and Inhibitors
(43)
Immunotherapy and Immune Responses
(28)
Frequent Co-Authors
Affiliations
Brigham and Women's Hospital
Memorial Sloan Kettering Cancer Center
National and Kapodistrian University of Athens
Hospital of the University of Pennsylvania
Pennsylvania Hospital